<DOC>
	<DOCNO>NCT02922374</DOCNO>
	<brief_summary>For acute severe colitis ( ASC ) patient , corticosteroid ( CS ) recommend first-line treatment guideline , patient great risk require colectomy turn second-line treatment . This study aim verify effectiveness ulcerative colitis endoscopic index severity ( UCEIS ) predict reaction corticosteroid , explore possibility noninvasive marker fecal calprotectin ( FC ) could act alternative UCEIS .</brief_summary>
	<brief_title>Ulcerative Colitis Endoscopic Index Severity Fecal Calprotectin Predict Reaction Corticosteroids Acute Severe Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>1 . Patients confirm diagnosis ASC accord Truelove Witt 's criterion ; 2 . Patients generally able tolerate flexible colonoscopy start CS treatment ; 1 . Patients incomplete colonoscopy , inadequate fecal sample ; 2 . Patients indeterminate diagnosis ASC ( colorectal cancer , Crohn 's disease ) accord colonoscopy ; 3 . Patients infectious colitis , Clostridium difficile CMV infection , primary immunodeficiency , recent history immunosuppressant within 3 month . 4 . Patients bowel resection , intestinal anastomotic , ileum enterostomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>acute severe colitis</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>UCEIS</keyword>
	<keyword>fecal calprotectin</keyword>
</DOC>